HBV Mutation Detail Information

> L180M Search Result


Mutation Information
Mutation Site L180M
Mutation Type Amino acid level
Gene/Protein/Region Type RT
Combined Mutation rt.L180M+rt.V173L+rt.M204V, rt.L180M+rt.M204V+rt.S202I
Genotype/Subtype E
Viral Reference X75657
Relevant Drug lamivudine
Country Nigeria
Literature Information
PubMed PMID 33446224
Clinical information Yes
Disease HBV-HIV coinfection
Published Year 2021
Journal Virology journal
Title Prevalence and characteristics of hepatitis B and D virus infections among HIV-positive individuals in Southwestern Nigeria.
Author Opaleye OO,Akanbi OA,Osundare FA,Wang B,Adesina O,Oluremi AS,Sunday ST,Akindele AA,Klink P,Bock CT
Evidence HBV DRMs V173L, L180M, S202I and M204V/I, which are associated with lamivudine resistance, were detected in 32.2% (n = 10/31) of the HBV DNA-positive samples.

Contents
Description
Mutation Information Note
  • Gene/Protein/Region Type: Virus Gene (e.g. LMP-1) or Virus Protein (e.g. Rep 68) or Virus Region (e.g. S, X)
Literature Information Note
  • Evidence: sentence contains this mutation information in the citation